• Chun Liu, Changhui Wu, Xiangde Zheng, Fanwei Zeng, Jinping Liu, Pingxi Wang, Fanxin Zeng, Lin Yuan, Fangcheng Zhu, Xuemei Gan, and Yucheng Huang.
• Department of Critical Care Medicine, Dazhou Central Hospital, Dazhou, Sichuan, China.
• J Formos Med Assoc. 2020 Nov 1; 119 (11): 170217091702-1709.

AbstractThe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome.© 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.

56 keywords...

hide…